Novo Nordisks reign as Europes most valuable company is facing a challenge from US rival Eli Lilly. Lillys weight-loss drug, Zepbound, is gaining market share, while Novos experimental drug showed less impressive results. This competition mirrors the Nok…
What can a wonder drug maker and a phone maker have in common? Their fall from grace
Published on December 21, 2024 by Banzai